Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease.
TL;DR: In this paper, the authors focus on recent progress that highlights the crucial role of alterations in mitochondrial function and oxidative stress in the pathogenesis of Alzheimer's disease, emphasizing a framework of existing and potential therapeutic approaches.
read more
Abstract: Mitochondria play a pivotal role in bioenergetics and respiratory functions, which are essential for the numerous biochemical processes underpinning cell viability. Mitochondrial morphology changes rapidly in response to external insults and changes in metabolic status via fission and fusion processes (so-called mitochondrial dynamics) that maintain mitochondrial quality and homeostasis. Damaged mitochondria are removed by a process known as mitophagy, which involves their degradation by a specific autophagosomal pathway. Over the last few years, remarkable efforts have been made to investigate the impact on the pathogenesis of Alzheimer's disease (AD) of various forms of mitochondrial dysfunction, such as excessive reactive oxygen species (ROS) production, mitochondrial Ca2+ dyshomeostasis, loss of ATP, and defects in mitochondrial dynamics and transport, and mitophagy. Recent research suggests that restoration of mitochondrial function by physical exercise, an antioxidant diet, or therapeutic approaches can delay the onset and slow the progression of AD. In this review, we focus on recent progress that highlights the crucial role of alterations in mitochondrial function and oxidative stress in the pathogenesis of AD, emphasizing a framework of existing and potential therapeutic approaches.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Daniel Mihai Teleanu,Adelina-Gabriela Niculescu,Iulia Ioana Lungu,Crina Ioana Radu,Oana Vladacenco,Eugenia Roza,B. Costachescu,Alexandru Mihai Grumezescu,Raluca Ioana Teleanu +8 more
TL;DR: The most common antioxidants, enzymatic as well as non-enzymatic, have been mentioned in this paper as therapeutic options for the discussed disorders.
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Charlotte Connell,Gwénaëlle Le Gall,Matthew G. Pontifex,Saber Sami,John F. Cryan,Gerard Clarke,Michael Müller,David Vauzour +7 more
TL;DR: This paper explored critical connections between microbial-derived metabolites (secondary bile acids, trimethylamine-Noxide (TMAO), tryptophan derivatives and others) and their influence upon cognitive function and neurodegenerative disorders, with a particular interest in their less explored role as risk factors of cognitive decline.
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok,Syed Suhail Andrabi,Saffar Mansoor,Youzhi Kuang,Brian K. Kwon,Vinod Labhasetwar +5 more
TL;DR: A comprehensive analysis of the potential of antioxidant therapy, challenges in their clinical translation, and the role nanoparticles/drug delivery systems could play in addressing these challenges is provided.
115
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes
Jiseon Lee,Hee Jin Kim +1 more
TL;DR: This review clarifies normal aging brain changes in an asymptotic and comprehensive manner, from a gross level to a microscopic and molecular level, and discusses potential approaches to seek the changes with cognitive decline.
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.
TL;DR: In this paper, a comprehensive literature review was conducted to identify and discuss the role of mitochondrial miRNAs that regulate mitochondrial and synaptic functions, and how synapse damage and mitochondrial dysfunctions contribute to AD; the structure and function of synapse and mitochondria in the disease process.
93
References
Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury
TL;DR: The results show that analogous to the cellular uptake, vitamin C enters mitochondria in its oxidized form via Glut1 and protects mitochondria from oxidative injury.
260
The Molecular Mechanism of Transport by the Mitochondrial ADP/ATP Carrier
Jonathan J. Ruprecht,Martin S. King,Thomas Zögg,Antoniya A. Aleksandrova,Els Pardon,Paul G. Crichton,Jan Steyaert,Edmund R.S. Kunji +7 more
TL;DR: The structure of the matrix-open state locked by bongkrekic acid bound in the ADP/ATP-binding site at the bottom of the central cavity is described and is likely to apply to the whole mitochondrial carrier family.
259
Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
TL;DR: It is proposed that reduced hippocampal phosphorylated tau is an important therapeutic strategy for AD and other tauopathies.
257
Role of PGC-1α signaling in skeletal muscle health and disease.
Chounghun Kang,Li Li Ji +1 more
TL;DR: PGC‐1α appears to play a protective role against atrophy‐linked skeletal muscle deterioration and upregulating nuclear respiratory factors and mitochondrial transcription factor A leads to increased mitochondrial DNA replication and gene transcription.
The chemical biology of S-nitrosothiols
TL;DR: This review attempts to describe the biological chemistry of S-nitrosation and to point out where the challenges lie in matching the known chemical biology of these compounds with their reported functions.
255